Bio Protocol said NeuroLab AI, a project built by NootropicsDAO, will begin its Ignition Sale on the Bio Protocol platform at 14:00 UTC on Sept. 16, with NDT as the token being offered. The sale will run for two weeks. Participation requires staking USDC, with users also able to pair their position with BioXP.
According to Bio Protocol, NeuroLab AI is designed to predict the potential effects of compounds on the brain and link molecular interactions with cognitive-equivalent effects, with the stated goal of helping researchers decide which candidates should move to the next round of lab testing. The project said its knowledge graph has organized more than 150,000 entries and over 8 million relationships.
The initial raise is set at $200,000, with a starting fully diluted valuation of $3 million and initial project funding of $100,000. Bio Protocol added that participant allocations will be 100% unlocked at claim, with no lock-up and no linear vesting. veBIO holders will receive a 20% allocation and can claim at any time, though any unvested portion is forfeited upon claiming. Of that allocation, 20% is unlocked at TGE and the remainder will vest linearly over six months. The Ignition Sale allocation is 6.67%.
Bio Protocol said NeuroLab AI, developed by NootropicsDAO, will start its Ignition Sale on Sept. 16 at 14:00 UTC on the Bio Protocol platform. The token on sale will be NDT, and the event will last for two weeks.
Users must stake USDC to participate and may choose to pair it with BioXP. For users who do not hold BioXP, Bio Protocol said they can obtain it by staking BIO or ecosystem tokens, or mint it instantly by spending BIO.
Project focus and data set
Bio Protocol said NeuroLab AI is built to predict the potential effects of compounds on the brain and connect molecular interactions with cognitive-equivalent effects. Its stated aim is to help researchers decide which candidates should be tested next in the lab.
The project said its knowledge graph has organized more than 150,000 entries and over 8 million relationships.
Fundraising size and token release terms
The initial raise is $200,000, with a starting fully diluted valuation of $3 million and initial project funding of $100,000.
Participant allocations will be 100% unlocked when claimed, with no lock-up period and no linear vesting.
Bio Protocol also said veBIO holders will receive a 20% allocation and can claim at any time. Any portion not yet released will be forfeited at the time of claim. Of that allocation, 20% is unlocked at TGE, with the remainder vesting linearly over six months. The Ignition Sale allocation is 6.67%.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
